Lilly Oncology Medical shared on X:
“Join us at ESMO 2026 for a rapid oral presentation on overall survival in the Phase 3 postMONARCH trial in HR+, HER2- advanced breast cancer following progression on prior CDK4/6i + ET.
1RO – Oct. 24, 10:59 -11:04 AM, Almeria Auditorium Hall 9.”
You can also read:
